
Created by @drbrowncares. Creator of #PrevCardioOnc. #CVDPrevention #cvPrev #HeartHealth #CVHealth #CardioOnc. Tweets≠employer's RT/Fol≠endorsement
Joined October 2018
- Tweets3.3K
- Following3.4K
- Followers1.6K
- Likes5.6K
Fall 2006: an MD/PhD student @drbrowncares decided to pursue #cvPrev. Fall 2010: the MD/PhD student decided to pursue #CardioOnc from the perspective of #cvPrev. Fall 2018: that physician scientist created @PrevCardioOnc. Winter 2018-2019: #PrevCardioOnc was born! #TogetherWeCan
Preventive Cardio-Oncology retweeted
A classic: timeless JAMA illustration of aortic and mitral valve vegetations invading the his-purkinje system.
This valvular – conduction system anatomic proximity is why we get serial EKGs in patients hospitalized with infective endocarditis 🏥 – at Los Angeles, CA
Preventive Cardio-Oncology retweeted
New meta-analysis shows systemic immune-mediated diseases are linked to a higher risk of cardiovascular death—highlighting the importance of integrated cardiometabolic care.
🔗 sciencedirect.com/science/ar…
#CardioResearch #HeartHealth #Inflammation #PreventiveCardiology
Preventive Cardio-Oncology retweeted
Strongly encourage this listen by national experts! This is a incredibly underapprectiated topic that has potential to magnify in importance throughtout 2026!!! @nationallipid @ASPCardio @society_eas @escardio @BNordestgaard @Drlipid @khurramn1 @CBallantyneMD
Don’t miss this FREE CME opportunity!
Elevated Lp(a) is a key risk enhancer for ASCVD. This 2-part on-demand series with Drs. Erin Michos & Pamela Morris breaks down what you need to know about Lp(a), LDL-C, and management strategies.
Start learning now: ow.ly/NVpn50XE8tP
@medliveofficial @ASPCardio
Preventive Cardio-Oncology retweeted
PCSK9i are associated with modest Lp(a) lowering of approximately 17% in real-world clinical practice, with a consistent percent reduction by baseline Lp(a) level, PCSK9i type, and Lp(a) assay type.
@ASPCardio @FamilyHeartFdn @UCSDHealthSci
Preventive Cardio-Oncology retweeted
ASPC members: New ICD-10-CM codes for familial hypercholesterolemia took effect Oct 1, 2025, under the FY 2026 IPPS rule.
• E78.010 HoFH
• E78.011 HeFH
• E78.019 FH, unspecified
Supports more precise FH documentation and coding. Details: Table 6A
ow.ly/gkVw50XK3Bf
Preventive Cardio-Oncology retweeted
New research links the PREVENT risk model with body fat distribution and subclinical left ventricular dysfunction, offering added insight into early cardiovascular risk stratification. Read more: ow.ly/ymfI50XKBo8
Preventive Cardio-Oncology retweeted
So excited to participate in this landmark @ScienceNews Science Translational Medicine study, which answers this with unprecedented mechanistic clarity. Here’s the clinical story ⬇️ Thanks @Nazish_Sayed for the honor @ICOSociety @md_addison @CardioOncology 1/
Excited 2 share our new paper @ScienceTM. V show how a cancer drug disrupts blood-vessel #mechanosensing via #PIEZO1, driving #hypertension & #cardiac dysfunction & how restoring #endothelial function protects🫀 @Joseph_C_Wu @maryhawn @StanfordSurgery
science.org/doi/10.1126/scit…
Preventive Cardio-Oncology retweeted
New nationwide cohort study links social determinants of health and Life’s Essential 8 metrics with cardiovascular morbidity and mortality, highlighting the impact of both social and behavioral factors on heart health.
🔗 ow.ly/OKpH50XLCQC
#HeartHealth #LifeEssentials8
Preventive Cardio-Oncology retweeted
Replying to @AmDiabetesAssn
@AmDiabetesAssn has released its 2026 Standards of Care in Diabetes, including updated guidance on cardiovascular disease risk management. Notable updates include language addressing fenofibrate & icosapent ethyl (IPE) in appropriate patient populations.
diabetesjournals.org/care/ar…
Preventive Cardio-Oncology retweeted
The international multicentre #RCT to assess the efficacy of personalized accelerated #pacing on a hierarchy of outcomes in #HFPEF is getting off the ground.
More to come..
Personalized accelerated pacing in #HFpEF patients with #pacemakers may reduce adverse events compared to standard 60 bpm pacing. ja.ma/4muQanL @maggieinfeld
Preventive Cardio-Oncology retweeted
We need to say Yes to challenges, we need to work to make that no women is left behind , you should become the mentor of other women #letsrise2025 #esccongress #wccardio @AnastasiaSMihai @Drroxmehran @WomenAs1
Preventive Cardio-Oncology retweeted
🔴 Heart failure improvement, remission, & recovery: A European Journal of Heart Failure expert consensus document @ESC_Journals #Cardiology #CardioEd @jozinetm
Preventive Cardio-Oncology retweeted
Late-Breaking Clinical Trials to Watch at #ESCcongress 2025 : Global Health and reshaping cardiovascular care priorities
📣Heart Failure
📍#DAPA ACT HF-TIMI 68 – #SGLT2i initiated during acute HF hospitalization
📍#VICTOR & #VICTORIA – Expanding vericiguat’s role in chronic HF
📍#PARACHUTE-HF – Sacubitril/valsartan vs enalapril in chronic Chagas cardiomyopathy
📣Myocardial Infarction / Beta-Blockers
📍#REBOOT-CNIC, #BETAMI, #DANBLOCK – Assessing the need for long-term beta-blockers in MI patients with preserved EF
📣Antithrombotic Therapy
📍#NEO-MINDSET, #TARGET FIRST, #DUAL-ACS, #ALONE-AF – Early withdrawal of aspirin or oral anticoagulants to reduce bleeding risk
📣HCM
📍#ODYSSEY-HCM & #MAPLE-HCM – Oral myosin inhibitors (mavacamten & aficamten) as alternatives to invasive strategies
📣Hypertension
📍#BaxHTN – New aldosterone synthase inhibitor
📍#KARDIA-3 – Zilebesiran, a twice-yearly siRNA therapy for long-term BP control
#LateBreakingRCT 📣 @escardio
Preventive Cardio-Oncology retweeted
Currently at #LetsRISE2025,
Inspirational talks by all the amazing leaders in #Cardiology at the House of Cardiology Roundtable 👏🏻👏🏻👏🏻
@Drroxmehran @ChrisKramerMD @ACCinTouch
@athenapoppas @worldheartfed
@drstaceyrosen @American_Heart
@TomLuscher @escardio
#RISE #ESCcongress #WomenInCardiology @WomenAs1
Preventive Cardio-Oncology retweeted
#KnowFH
This is part of our special series on #FH & Lp(a) from the 20205 @FamilyHeartFdn meeting
🚨Pediatric Screening needs to occur to #FindFH : early detection saves lives but rarely happens
#CVprev @ASPCardio @AJPCardio @hillypaige2
New review introduces the LEAD framework—Leveraging Evidence and Data—to strengthen pediatric screening protocols for familial hypercholesterolemia (FH). Early detection, backed by solid data, can save lives.
Read more: ow.ly/fPIT50WN1F9
Preventive Cardio-Oncology retweeted
Personalized accelerated pacing in #HFpEF patients with #pacemakers may reduce adverse events compared to standard 60 bpm pacing. ja.ma/4muQanL @maggieinfeld
Preventive Cardio-Oncology retweeted
🩸 Not all LDL is equal! Small dense LDL-C (sdLDL-C) 🧬—and its ratios—predict carotid plaque 🫀 risk better than LDL-C or non-HDL-C. This study shows sdLDL-C metrics add key risk info for prevention 💡
Full study 👉 jacc.org/doi/10.1016/j.jacas…
#JACCAsia #cvPrev #cvLipids #ACCIntl
Preventive Cardio-Oncology retweeted
Thank you for sharing our paper led by Dr. Majmundar and Dr. Patel on mode of delivery on maternal & fetal outcomes in patients with #Heartfailure or #PulmonaryHTN
Fetal outcomes better with C-section but at the expense of the mother
#cardioobstetrics. @ASPCardio @AJPCardio @SmidtHeart @CedarsSinaiMed
New study: In pregnant patients with heart failure or pulmonary hypertension, cesarean delivery was linked to lower fetal mortality but came with increased maternal risk in-hospital. Critical insights for delivery planning in high-risk pregnancies.
ow.ly/cIih50WN1Tt
Preventive Cardio-Oncology retweeted
A new and outstanding @NEJM review on the impact of A.I. on the practice of medicine and education, with scenarios of deskilling, mis-skilling, never-skilling, or the optimum of enhanced practice nejm.org/doi/full/10.1056/NE… @BageLeMage
Preventive Cardio-Oncology retweeted
"I chose to become an FACC for professional growth, leadership development, advocacy, & networking w/ like-minded CV professionals w/ a passion for patient care & research." – Dr. Brenton Scott Bauer, FACC
Learn more & advance to FACC today ➡️ bit.ly/4gjfOIH
#ACCFIT







































